15/04/2014 - 21:15
Albiglutide, a once-weekly subcutaneous injection, has been approved by the Food and Drug Administration to improve glycemic control, in conjunction with diet and exercise in type 2...
Field of Interest: Endocrinology
Categories:
News Feed: Internal Medicine News - Endocrinology